Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
DE0006569908
Mon, 19.02.2024
MLP SE
Case fully intact despite PW; chg.
Topic: MLP released a profit warning and is now expecting an FY'23 EBIT of
€ 71m, thus missing the guidance of € 75-85m due to € 4m of goodwill
impairments in the real estate business.
Below market expectations: Adjusting for the impairment, the guidance range
should have been met at the lower [ … ]
Thu, 25.01.2024
MLP SE
Low risk, high reward - added to NuWays' Alpha List
At current levels, MLP’s stock offers a strong upside potential while
potential downside risks seem priced in and should not impact bottom line
significantly. Here is our take:
(1) Strong diversification of negatively correlated business segments
protects MLP against changing macroecon [ … ]
Fri, 15.12.2023
MLP SE
Prepared for the future - Analyst meeting feedback
Topic: MLP recently hosted its annual analyst meeting and gave insights
into strategic developments:
Advanced digitalization: On group level as well as for all MLP consultants,
the company has invested heavily into its digitalization. For example, AI
enabled robotic process automations signif [ … ]
Fri, 10.11.2023
MLP SE
Q3 review: too cheap to ignore resilience
Total sales grew slightly by 4% yoy to € 208m (eNuW: € 215m) thanks to
MLP’s diversified sales mix.
Growth was recorded in the areas of Non-Life Insurance (€ 34m, +16% yoy;
eNuW: € 36m), Interest Income (€ 18m, +259% yoy; eNuW: € 17m), Old-Age
Provision (€ 51m, [ … ]